GCTK Stock Price, Chart, Stats & News

GlucoTrack, Inc.
Save
209,108
Market cap
0.06x
Current P/E
–
Forward P/E
GCTK chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -311.87% |
ROE | -2659.19% |
D/E | 0.01x |
Interest coverage ratio | – |
GCTK valuation
P/E | 0.06x |
P/S | – |
P/B | 0.32x |
P/CF | -0.06x |
P/FCF | -0.04x |
P/OCF | -0.06x |
PEG | -0.00x |
EV multiple | -0.33x |
About
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe.
Similar securities
Based on sector and market capitalization
Report issue










